Articles Tagged With: Abortion
-
Abortion for Fetal Anomalies: Trends in Gestational Age
In this retrospective cohort study, the median gestational age at the time of abortion for fetal aneuploidy decreased from 19 weeks in 2004 to 14 weeks in 2014. However, the gestational age at the time of abortion for fetal structural abnormalities remained at ≥ 20 weeks over the study period.
-
When to Start Progestin-only Contraceptives After Medical Abortion
In this randomized, controlled trial, provision of depot medroxyprogesterone acetate on the same day as mifepristone for medical abortion decreased efficacy a small amount and had no effect on repeat pregnancy at six months. Whether this is clinically relevant will depend on individual patient counseling and the woman’s desire for convenient contraceptive coverage.
-
Church Amendment Protects Abortion Views
The Church Amendment that a physician is citing in her claims that a hospital restricted her speech on abortion normally is invoked by healthcare providers on the other side of the controversial issue, says John E. Petite, JD, an attorney with the law firm Greensfelder in St. Louis.
-
Complaint Alleges Effort to Silence Doctor
In the Office for Civil Rights complaint filed by Diane J. Horvath-Cosper, MD, an obstetrician-gynecologist and fellow at MedStar Washington Hospital Center in Washington, DC, she outlines what she says was an insistence by hospital administrators to stop her from talking publicly about abortion.
-
Hospital Faces OCR Complaint for Gag Order on Abortion
The case raises important questions about how much a healthcare employer can restrict employees’ private activities.
-
What Is the Best Way to Perform a Paracervical Block?
ABSTRACT & COMMENTARY: A randomized, controlled trial of first-trimester suction D&C procedures.
-
Medicaid Pushes Forward on Family Planning
With the end of the Obama administration rapidly approaching, federal agencies have stepped up their efforts to finalize long-brewing regulations and guidance. CMS has been particularly active. In April 2016, the agency issued three documents that all have considerable importance for family planning services and providers under Medicaid.
-
FDA Updates Mifepristone Labeling, Easing Access to Abortion Pill
The Food and Drug Administration has approved new and updated labeling for the medication abortion drug mifepristone (Mifeprex, Danco Laboratories, New York City) to reflect the most current clinical practices and safety and efficacy data. The drug’s new label reduces the size of the initial dose and extends the window for taking it to 70 days since the first day of a woman’s last menstrual period.
-
Oral Fluconazole During Pregnancy Increases Risk for Spontaneous Abortion
A nationwide cohort study from Denmark found a significantly increased risk of spontaneous abortion associated with oral fluconazole usage. Caution with this medication during pregnancy is advised.
-
Does a History of D&C Increase the Risk of Premature Delivery?
In a meta-analysis, a history of dilation and curettage for management of miscarriage or termination of pregnancy was associated with an increased risk of preterm birth in a subsequent pregnancy but the association is weak and most likely explained by confounding.